Details for New Drug Application (NDA): 203741
✉ Email this page to a colleague
The generic ingredient in NEBIVOLOL HYDROCHLORIDE is nebivolol hydrochloride. There are fourteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nebivolol hydrochloride profile page.
Summary for 203741
Tradename: | NEBIVOLOL HYDROCHLORIDE |
Applicant: | Alkem Labs Ltd |
Ingredient: | nebivolol hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 203741
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2.5MG BASE | ||||
Approval Date: | Jun 24, 2015 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Jun 24, 2015 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jun 24, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription